These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 17716993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
    Xie S, Li W, Ren Z, Zhang J, Guo X, Wang S, Huang S, Zeng F, Zeng YT.
    J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
    [Abstract] [Full Text] [Related]

  • 4. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P, Arumugam PI, Yee JK, Puthenveetil G.
    Ann N Y Acad Sci; 2005 Oct; 1054():238-49. PubMed ID: 16339671
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
    Gu X, Gong L, Zhang W.
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 Nov; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
    Dalle B, Payen E, Regulier E, Deglon N, Rouyer-Fessard P, Beuzard Y, Aebischer P.
    Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R, Gilman JG, Feng YQ, Marmorato A, Rochlin I, Suzuka SM, Fabry ME, Nagel RL, Bouhassira EE.
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ, Rybicki AC, Suzuka SM, Hall CB, Breuer W, Cabantchik ZI, Bouhassira EE, Fabry ME, Nagel RL.
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
    Tubsuwan A, Munkongdee T, Jearawiriyapaisarn N, Boonchoy C, Winichagoon P, Fucharoen S, Svasti S.
    Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.